West Pharmaceutical Services EPS - Earnings per Share 2010-2024 | WST

West Pharmaceutical Services annual and quarterly earnings per share history from 2010 to 2024. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
  • West Pharmaceutical Services EPS for the quarter ending March 31, 2024 was $1.55, a 16.22% decline year-over-year.
  • West Pharmaceutical Services EPS for the twelve months ending March 31, 2024 was $7.58, a 3.98% increase year-over-year.
  • West Pharmaceutical Services 2023 annual EPS was $7.88, a 1.94% increase from 2022.
  • West Pharmaceutical Services 2022 annual EPS was $7.73, a 10.84% decline from 2021.
  • West Pharmaceutical Services 2021 annual EPS was $8.67, a 89.72% increase from 2020.
West Pharmaceutical Services Annual EPS
2023 $7.88
2022 $7.73
2021 $8.67
2020 $4.57
2019 $3.21
2018 $2.74
2017 $1.99
2016 $1.91
2015 $1.30
2014 $1.75
2013 $1.57
2012 $1.15
2011 $1.08
2010 $0.95
2009 $1.06
West Pharmaceutical Services Quarterly EPS
2024-03-31 $1.55
2023-12-31 $1.83
2023-09-30 $2.14
2023-06-30 $2.06
2023-03-31 $1.85
2022-12-31 $1.37
2022-09-30 $1.59
2022-06-30 $2.48
2022-03-31 $2.29
2021-12-31 $1.90
2021-09-30 $2.31
2021-06-30 $2.47
2021-03-31 $1.99
2020-12-31 $1.28
2020-09-30 $1.09
2020-06-30 $1.21
2020-03-31 $0.99
2019-12-31 $0.85
2019-09-30 $0.75
2019-06-30 $0.88
2019-03-31 $0.73
2018-12-31 $0.68
2018-09-30 $0.73
2018-06-30 $0.75
2018-03-31 $0.58
2017-12-31 $0.00
2017-09-30 $0.67
2017-06-30 $0.51
2017-03-31 $0.81
2016-12-31 $0.51
2016-09-30 $0.50
2016-06-30 $0.60
2016-03-31 $0.30
2015-12-31 $0.45
2015-09-30 $0.02
2015-06-30 $0.38
2015-03-31 $0.45
2014-12-31 $0.42
2014-09-30 $0.43
2014-06-30 $0.52
2014-03-31 $0.38
2013-12-31 $0.32
2013-09-30 $0.37
2013-06-30 $0.43
2013-03-31 $0.45
2012-12-31 $0.31
2012-09-30 $0.21
2012-06-30 $0.23
2012-03-31 $0.41
2011-12-31 $0.27
2011-09-30 $0.25
2011-06-30 $0.29
2011-03-31 $0.28
2010-12-31 $0.10
2010-09-30 $0.26
2010-06-30 $0.31
2010-03-31 $0.29
2009-12-31 $0.30
2009-09-30 $0.25
2009-06-30 $0.29
2009-03-31 $0.23
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $24.159B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $72.887B 20.45
Becton Dickinson (BDX) United States $66.122B 18.71
Cardinal Health (CAH) United States $23.477B 13.43
Align Technology (ALGN) United States $19.244B 37.15
Cooper (COO) United States $18.860B 28.54
Labcorp (LH) United States $16.830B 14.49
Henry Schein (HSIC) United States $9.184B 16.34
DENTSPLY SIRONA (XRAY) United States $5.702B 14.76
Merit Medical Systems (MMSI) United States $4.760B 26.09
CONMED (CNMD) United States $2.281B 20.69
Patterson (PDCO) United States $2.145B 10.27
STAAR Surgical (STAA) United States $2.022B 77.66
Atrion (ATRI) United States $0.815B 43.51
Lifevantage (LFVN) United States $0.096B 12.34
Pro-Dex (PDEX) United States $0.067B 34.03
Biolase (BIOL) United States $0.006B 0.00